Precipio (PRPO) vs Quanterix (QTRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Precipio (PRPO) has outperformed Quanterix (QTRX) over the past year, gaining 26.4% versus a loss of 46.5%. Over five years, PRPO leads with a -54.7% price change compared with -93.8% for QTRX. Quanterix is the larger company by market cap ($151.8 million vs $41.5 million), about 3.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PRPO | QTRX |
|---|---|---|
| Share price | $23.19 | $3.21 |
| Market cap | $41.51M | $151.81M |
| 1-day change | -1.40% | -3.46% |
| YTD return | +0.91% | -49.53% |
| 1-year return | +26.38% | -46.50% |
| 5-year return | -54.71% | -93.79% |
| Forward P/E | 59.46 | — |
| EPS (TTM) | $-0.64 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $33.63 | $8.77 |
| 52-week low | $16.40 | $2.15 |
| Distance from 52-week high | -31.04% | -63.40% |
| Analyst consensus | — | none |
| Avg. price target upside | — | -6.54% |
| Average volume | 128.13K | 762.14K |
| Shares outstanding | 1.79M | 47.29M |
| Employees | 61 | 450 |
| Sector | Healthcare | Industrials |
| Industry | Diagnostics & Research | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Quanterix is about 3.7 times larger than Precipio by market value ($151.81M vs $41.51M).
- PRPO has outperformed QTRX by 72.9 percentage points over the past year.
- The two companies sit in different sectors: Precipio in Healthcare and Quanterix in Industrials.
About Precipio
PRPO stock →Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
Healthcare · Diagnostics & Research · 61 employees
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
PRPO vs QTRX FAQ
Which is bigger, Precipio or Quanterix?
Quanterix (QTRX) is larger, with a market capitalization of $151.81M compared with $41.51M for Precipio (PRPO).
Which stock has performed better over the past year, PRPO or QTRX?
PRPO returned +26.38% over the past 12 months, compared with -46.50% for QTRX (price return, excluding dividends). Past performance does not predict future results.
Are Precipio and Quanterix in the same industry?
No. Precipio is in the Healthcare sector, while Quanterix is in Industrials.